期刊文献+

维持性血液透析患者血清甲状旁腺激素水平与心功能评价的相关性研究 被引量:6

The association between parathyroid hormone and cardiac function in patients under maintenance hemodialysis
下载PDF
导出
摘要 目的 探讨维持性血液透析(MHD)患者全段甲状旁腺激素(iPTH)水平的变化与左心室结构和功能的相关性,评估iPTH对MHD合并心力衰竭早期诊断、治疗及判定预后的临床价值。方法 随机选取沈阳军区总医院血液净化科186名MHD患者。入选标准为:血液透析3次/周,每次4h;年龄在18~75岁;透析年限6个月以上,10年以下;无急性心血管事件。利用放免法检测患者透析前iPTH水平、电化学发光免疫分析法检测透析血浆B型钠尿肽前体(pro—BNP)水平。左心室肥厚(LVH)可由心脏超声检查判断。超声心动图检测患者左心房内径(LAD)、左心室舒张末内径(LVDd)、室间隔厚度(IVST)、左心室后壁厚度(LVPwT)、左心室射血分数(LVEF)等,计算左心室重量(LVM),左心室心肌重量指数(LVMI)。根据2009年KDIGO指南iPTH水平的目标范围,按iPTH正常参考值上限水平2~9倍为界将患者分为3组,探讨iPTH与MHD患者左心功能的关系。结果 iPTH≥549.9pg/ml组患者的LAD、LVMI、LVDd、IVST、LVPwT显著高于iPTH≤122.2pg/ml,122.2~549.9pg/ml组(P〈0.05)。随着iPTH的增长,患者pro—BNP水平升高,有统计学差异(P〈0.05)。随着iPTH的增长,iPTH与NYHA心功能分级呈正相关,血清iPTH水平与LAD、LVMI、LVDd、LVDs、IVST、LVPwT、左心室收缩功能、pro—BNP呈正相关(P〈0.05),与LVEF呈负相关(P〈0.05)。结论 MHD患者iPTH水平与左心室功能密切相关,可能成为诊断及评估患者心功能的一个重要标志物。 Objective To investigate the relationship between intact parathyroid hormone (iPTH) and left ventricular structure and function, and to evaluate the clinical value of iPTH for the early diagnosis, treatment and prognosis of heart failure. Methods A total of 186 maintenance hemodialysis (MHD) patients treated in Hospital of Shenyang Military Area Command were recruited in this study. They were treated with maintenance hemodialysis (MHD) 3 times a week and 4 h a session with the dialysis age of 6 months to 10 years, and were 18-75 years old without acute cardiovascular events. Serum iPTH was determined by radioimmunoasssy, and pro-BNP by electro-chemiluminescence. Eehocadiography was used to measure left atrial size (LAD), ventricular diastolic diameter (LVDd), interventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPwT), left ventrieular ejection fraction (LVEF), left ventricular mass (LVM) and LVM index (LVMI) for the assay of left ventricular hypertrophy. According to the 2009 KDIGO guidance and 2~9 times of iPTH upper limits (normal range 11.7~61.1 pg/ml), the patients were stratified into three groups, iPTH ≥549.9 pg/ml group, iPTH ≤122.2 pg/ml group and 122.2~549.9 pg/ml group to investigate the relationship between iPTH and left ventricular structure and function. Result LAD, LVMI, LVDd, VST and LVPwT were significantly higher in the iPTH ≥549.9 pg/ml group than those in the iPTH ≤122.2 pg/ml and 122.2~549.9 pg/ml groups (P〈0.05). Serum iPTH was positively correlated with pro-BNP levels (P〈0.05). Serum iPTH increased along with the increase of NYHA class, iPTH level was positively correlated with LAD, LVMI, LVDd, LVDs, IVST, LVPwT, left ventrieular systolic function and pro-BNP (P〈0.05), and was negatively correlated with LVEF (P〈0.05). Conclusion In MHD patients, serum iPTH is closely related to left ventricular function, iPTH may become an important factor for the evaluation of heart function.
出处 《中国血液净化》 2014年第7期506-509,共4页 Chinese Journal of Blood Purification
基金 辽宁省科技攻关课题(2012408002)
关键词 维持性血液透析 甲状旁腺激素 NYHA心功能分级 Maintenance hemodialysis, parathyroid hormone. NYHA functional class
  • 相关文献

参考文献20

  • 1Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B., and Castelli, W.P. 1990. Prognostic implications of ecbocardiographically determined left ventrieular mass in the Framingham Heart Study[J]. N Engl J Med 322: 1561-1566.
  • 2Investigators, E.T., Chertow, G.M., Block, G.A., Correa- Rotter, R., Drueke, T.B., Floege, J., Goodman, W.G., Herzog, C.A., Kubo, Y., London, G.M., et al. 2012. Ef- fect of cinacaicet on cardiovascular disease in pa- tients undergoing dialysis[J]. N Engl J Med 367:2482- 2494.
  • 3Daimon, M., Watanabe, H., Abe, Y., Hirata, K., Hozumi, T., Ishii, K., Ito, H., Iwakura, K., Izumi, C., Matsu- zaki, M., et al. 2011. Gender differences in age relat- ed changes in left and right ventricular geometries and functions. Ecbocardiography of a healthy subject group[J]. Circ J 75:2840-2846.
  • 4Manabe, I. 2011. Chronic inflammation links cardiovas- cular, metabolic and renal diseases[J]. Circ J 75:2739 2748.
  • 5Hruska, K.A., Choi, E.T., Memon, I., Davis, T.K., and Mathew, S. 2010. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD) [J]. Pediatr Nephrol 25:769-778.
  • 6Palmer, S.C., Navaneethan, S.D., Craig, J.C., Johnson, D.W., Tonelli, M., Garg, A.X., Pellegrini, F., Ravani, P., Jardine, M., Perkovic, V., et al. 2010. Meta-analy- sis: erythropoiesis stimulating agents in patients with chronic kidney disease[J]. Ann Intern Med 153:23- 33.
  • 7Paoletti, E., Specchia, C., Di Maio, G., Bellino, D., Damasio, B., Cassottana, P., and Cannella, G. 2004. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodi- alysis patients: a 10 year survey[J]. Nephrol Dial Transplant 19:1829-1834.
  • 8Qing, D.P., Ding, H., Vadgama, J., Wu, Y.Y., and Kop- ple, J.D. 1999. Elevated myocardial cytosolic calcium impairs insulin- like growth factor- 1- stimulated pro- tein synthesis in chronic renal failure[J]. J Am Soc Nephrol 10:84 92.
  • 9Paoletti E, Specchia C, Di iaio Get al (2004) The wors- ening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis pa- tients: a 10 year survey[J]. Nephrol Dial Transplant, 19:1829 - 1834.
  • 10Fujii, H., Kim, J.I., Abe, T., Umezu, M., and Fukaga- wa, M. 2007. Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis patients [J]. Intern Med 46:1507-1512.

同被引文献49

  • 1QING D P, DING H, VADGAMA J, et al. Elevated myocardial cytosolic calcium impairs ins.ulinlike growth factor-l-stimulated protein synthesis in chron- ic renal failure[J]. J Am Soc Nephrol, 10 :84- 92.
  • 2ZIA A A, KAMALOV G, NEWMAN K P, et al. From aldosteronism to oxidative stress., the role of excessive intraeellular calcium accumulation[J]. Hypertens Res, 33:1091-1101.
  • 3DAIMON M, WATANABE H, ABE Y, et al. Gender differences in age-related changes in left and right ven- tricular geometries and functions. Echocardiograpby of a healthy subject group[J]. Circ J, 2011,75 : 2840- 2846.
  • 4EVOLVE Trial Investigators, CHERTOW G M, BLOCK G A, et al. Effect of cinacalcet on cardiovascu- lar disease in patients undergoing dialysis[J]. N Engl J Med,2012, 367:2482-2494.
  • 5MAOR Y,KING M, OLMER L, et al. A comparison of three methods, the time trade-off technique, global healthy related quality of life and the SF 36 in dialysis patients[J]. J Clin Epidemiol, 2001,54 : 565- 570.
  • 6王志刚.血液净化.第2版.北京:北京科学技术出版社,2003:566.
  • 7Gismondi RA, Neves MF, Oigman W, et al. Ambulatory arterial stiffness index is higher in hypertensive patients with chronic kidney disease. International Journal of Hypertension, 2012:178078. Flythe JE,.
  • 8Kunaparaju S, Dinesh K, et al, Factors associated with intradialytic systolic blood pressure variability.American Journal of Kidney Diseases the Official Journal of the National Kidney Foundation, 2012, 59(3):409-418.
  • 9姜培静,谢昕.左卡尼汀对血液透析患者心功能改善的疗效观察[J].中外医疗,2008,27(14):69-69. 被引量:2
  • 10钟丹,陈小丽,唐芳根,延卫东,罗红娥,李梦军.SF-36量表在慢性肾衰患者生存质量评价分析中的应用[J].井冈山大学学报(自然科学版),2010,31(1):112-115. 被引量:12

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部